Market Tracker

08/26 5:16pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.33
Delayed Data
As of Aug 26
 +1.16 / +8.19%
Today’s Change
6.91
Today|||52-Week Range
15.38
+64.66%
Year-to-Date
Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling
Aug 26 / TheStreet.com - Paid Partner Content
Vanda Pharmaceuticals (VNDA) Catches Eye: Stocks Up 20%
Aug 26 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for Vanda Pharmaceuticals (VNDA)?
Aug 26 / Zacks.com - Paid Partner Content
Why Tiffany, AEP Industries, and Vanda Pharmaceuticals Jumped Today
Aug 25 / MotleyFool.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
Aug 26 / Zacks.com - Paid Partner Content
Vanda Pharmaceuticals (VNDA) Stock Soars on Drug Patent Ruling
Aug 25 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close14.17
Today’s open14.50
Day’s range14.18 - 15.38
Volume2,668,441
Average volume (3 months)645,418
Market cap$663.5M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-8.89%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...+0.23+1.27%
ZIOPZIOPHARM Oncology In...+0.09+1.74%
DVAXDynavax Technologies...+0.17+1.06%
AIMTAimmune Therapeutics...+0.15+1.03%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts